Cleared Traditional

K123998 - QUIDEL MOLECULAR DIRECT C. DIFFICILE ASSAY
(FDA 510(k) Clearance)

Mar 2013
Decision
72d
Days
Class 2
Risk

K123998 is an FDA 510(k) clearance for the QUIDEL MOLECULAR DIRECT C. DIFFICILE ASSAY. This device is classified as a C. Difficile Toxin Gene Amplification Assay (Class II - Special Controls, product code OZN).

Submitted by Quidel Corp. (San Diego, US). The FDA issued a Cleared decision on March 8, 2013, 72 days after receiving the submission on December 26, 2012.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3130. Amplification Assay For The Detection Of C. Difficile Toxin Genes From Stool Specimens Of Symptomatic Patients..

Submission Details

510(k) Number K123998 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 2012
Decision Date March 08, 2013
Days to Decision 72 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code OZN — C. Difficile Toxin Gene Amplification Assay
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3130
Definition Amplification Assay For The Detection Of C. Difficile Toxin Genes From Stool Specimens Of Symptomatic Patients.

Similar Devices — OZN C. Difficile Toxin Gene Amplification Assay

All 16
Xpert C. difficile/Epi
K243730 · Cepheid · Feb 2025
Great Basin Toxigenic C. difficile Direct Test (CDF2)
K232092 · Vela Operations USA · Nov 2023
cobas Cdiff nucleic acid test for use on the cobas Liat System
K212427 · Roche Molecular Systems, Inc. · Oct 2021
cobas Cdiff nucleic acid test for use on the cobas Liat System
K210385 · Roche Molecular Systems, Inc. · Sep 2021
GenePOC CDiff
K172569 · Genepoc, Inc. · Nov 2017
cobas Cdiff Nucleic acid test for use on the cobas Liat System
K171770 · Roche Molecular Systems, Inc. · Sep 2017